Finance

Lists
RANI:NASDAQ
Rani Therapeutics Holdings Inc
$0.84
+0.24%
(+0.0020) 1D
Sep 10, 11:01:27 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RANI...
Open
$0.85
High
$0.85
Low
$0.83
Mkt. cap
117.71M
Avg. vol.
641.87K
Volume
67.00K
52-wk high
$3.87
52-wk low
$0.45
EPS
-$0.26
Beta
0.69
Shares outstanding
115.42M
No. of employees
70
Open
$0.85
High
$0.85
Low
$0.83
Mkt. cap
117.71M
Avg. vol.
641.87K
Volume
67.00K
52-wk high
$3.87
52-wk low
$0.45
EPS
-$0.26
Beta
0.69
Shares outstanding
115.42M
No. of employees
70
News stories
From web sources and news partners
About Rani Therapeutics Holdings Inc
CEO-
Employees70
Founded2012
Headquarters-
SectorPharmaceutical industry
Websiteranitherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to RANI in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for RANI in the last 3 months.
Highest
Current $0.84
$11.00 (+1,206.41%)
Average
$6.75 (+701.66%)
Lowest
$5.00 (+493.82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
$11.00
+1,206.4%
08/21/2026
Michael Okunewitch
Maxim Group
Buy
Maintained
$5.00
+493.8%
08/20/2026
Andreas Argyrides
Chardan Capital
Buy
Initiated
$6.00
+612.6%
08/18/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
$5.00
+493.8%
08/17/2026
Daniel Brims
Lake Street
Buy
Reiterated
$9.00
+968.9%
05/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
1.46M
1.71M
1.71M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.22M
4.91M
5.16M
5.02M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.04M
5.09M
4.89M
5.52M
Operating expense
7.26M
10.00M
10.05M
10.54M
Total operating expenses
7.26M
10.00M
10.05M
10.54M
Operating income
-7.26M
-8.54M
-8.34M
-8.83M
Other non operating income
-
-
-
-
EBT including unusual items
-7.91M
-9.07M
-8.02M
-8.42M
EBT excluding unusual items
-7.91M
-8.50M
-8.02M
-8.42M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.41M
-10.30M
-7.03M
-7.39M
Net profit margin
-
-705.34%
-411.77%
-432.73%
Earnings per share
-0.12
-0.07
-0.04
-0.04
Interest and investment income
68.00K
384.00K
412.00K
415.00K
Interest expense
-725.00K
-347.00K
-88.00K
-8.00K
Net interest expenses
-657.00K
37.00K
324.00K
407.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.03M
-8.35M
-8.18M
-8.68M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps